Peptidic Collaborations: A Joint Strategy to Drug Development
Often, drug development has focused on minute compounds, but peptidic partners are rapidly gaining traction. This new strategy involves combining peptidic sequences with complementary medicinal modalities to confront complex illness targets. By employing the distinctive features of amino acid seq